|
ZYG11B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.79851747015437E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52076137741142E-12 |
| Normal-vs-Stage2 |
1.9169999998514E-07 |
| Normal-vs-Stage3 |
1.99869999994995E-06 |
| Normal-vs-Stage4 |
1.56900999999099E-05 |
| Stage1-vs-Stage2 |
5.983200E-01 |
| Stage1-vs-Stage3 |
5.091000E-01 |
| Stage1-vs-Stage4 |
8.608200E-01 |
| Stage2-vs-Stage3 |
9.545000E-01 |
| Stage2-vs-Stage4 |
5.632600E-01 |
| Stage3-vs-Stage4 |
5.769000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59625654308593E-12 |
| Normal-vs-AfricanAmerican |
7.0904999982524E-08 |
| Normal-vs-Asian |
5.209800E-04 |
| Caucasian-vs-AfricanAmerican |
8.248800E-01 |
| Caucasian-vs-Asian |
8.569000E-01 |
| AfricanAmerican-vs-Asian |
8.500000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6251444634463E-12 |
| Normal-vs-Female |
1.032240E-04 |
| Male-vs-Female |
5.284800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.21639999999912E-05 |
| Normal-vs-Extreme_Weight |
1.9408918916497E-12 |
| Normal-vs-Obese |
3.71100039586736E-10 |
| Normal-vs-Extreme_Obese |
2.17059999996216E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.954400E-01 |
| Normal_Weight-vs-Obese |
9.516400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.707800E-01 |
| Extreme_Weight-vs-Obese |
1.653020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.563800E-01 |
| Obese-vs-Extreme_Obese |
7.809800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.91079999951094E-07 |
| Normal-vs-Age(41-60Yrs) |
8.71840044602834E-10 |
| Normal-vs-Age(61-80Yrs) |
2.70006239588838E-13 |
| Normal-vs-Age(81-100Yrs) |
9.13519999978796E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.138800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.201000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.249000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.042400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.050600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.457800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
5.0481000046787E-08 |
| Normal-VS-KIRP CIMP |
1.93728999999809E-05 |
| Normal-VS-Unclassified PRCC |
2.14689999999962E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.206400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.394200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.710420E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.142800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.762200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.249200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99174010617753E-13 |
| Normal-vs-N1 |
3.87139999999953E-05 |
| Normal-vs-N2 |
1.624040E-03 |
| N0-vs-N1 |
2.913000E-01 |
| N0-vs-N2 |
7.673000E-01 |
| N1-vs-N2 |
8.045800E-01 |
|
|
